Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rank in Stocks #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.40
Last synced: 2026-08-18
Market Cap
$28.25M
Change (1 day)
0.00%
Change (1 year)
536.36%
Country
IL
Trade Raphael Pharmaceutical Inc. (RAPH)

Category

Operating Margin for Raphael Pharmaceutical Inc. (RAPH)
Operating Margin as of 2026 TTM: 0.00%
According to Raphael Pharmaceutical Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Raphael Pharmaceutical Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.